Latest AI and machine learning research in breast cancer for healthcare professionals.
The therapeutic landscape of colorectal cancer (CRC) has evolved with the identification of molecular subtypes, including mismatch repair-deficient/microsatellite instability-high, POLE mutations, RAS/BRAF alterations, and HER2 amplification, enabling use of precision therapies and immune checkpoint inhibitors for selected populations. However, most microsatellite-stable (MSS) tumors remain resist...
BACKGROUND: Clavien-Dindo (CD) grade ≥II complications occur in roughly one in five patients after curative gastrectomy for gastric cancer and independently shorten overall survival (OS) by compromising adjuvant therapy delivery. Current nutritional, inflammatory and global surgical risk scores identify only a minority of affected patients. We developed and validated a multi-modal deep learning fr...
Advanced pancreatic ductal adenocarcinoma (PDAC) often progresses rapidly during chemotherapy despite initial assessments of stable disease or partial...
BACKGROUND: Accurate delineation of target volumes and organs at risk (OAR) is essential in radiotherapy planning for cervical cancer. Deep learning (...
BACKGROUND: Positron emission tomography with magnetic resonance imaging (PET/MRI) provides noninvasive molecular characterization of breast cancer an...
Gastric cancer (GC) shows strong biological heterogeneity and frequent disruption of inflammatory and metabolic programs, which affect tumor progressi...
BACKGROUND: Diagnosing breast cancer with mammography continues to be an incidentally challenging process because of the numerous different ways of ac...
OBJECTIVE: Develop a multimodal fusion model combining MRI radiomics and deep learning (DL) to predict pathologic complete response (pCR) in breast ca...
BACKGROUND AND OBJECTIVES: Myxopapillary ependymomas (MPE) and intradural lumbosacral schwannomas may be challenging to distinguish based on presentin...
Non-small cell lung cancer (NSCLC) is the most common cancer-related cause of death among all countries globally, mostly because of late diagnosis, he...
Predicting cancer drug responses (CDRs) accurately remains a significant challenge due to the complexity of tumor biology and the limitations of exist...
RATIONALE AND OBJECTIVES: To develop and compare general and treatment-specific radiomics models based on pretreatment computed tomography (CT) for pr...
Accurate global solar radiation (GSR) forecasting is vital for smart grids and resilient energy systems. However, the nonlinear and non-stationary nat...
Prognostic heterogeneity remains a challenge for non-metastatic renal cell carcinoma (RCC) patients following radical nephrectomy (RN). This study aim...
Head and neck squamous cell carcinoma (HNSCC) is a highly heterogeneous malignancy with poor prognosis, accompanied by metabolic reprogramming and tum...
BACKGROUND: Neoadjuvant chemotherapy (NACT) is an established treatment strategy for advanced epithelial ovarian cancer, particularly for patients wit...
Accurate prediction of breast cancer recurrence remains difficult because prognosis varies significantly across molecular subtypes. This underscores t...
PURPOSE: Cancer-associated fibroblasts (CAFs) are central drivers of PDAC progression and therapeutic resistance, yet their preoperative clinical util...
BACKGROUND: Aortic valve calcium scoring by computed tomography (CT) is an established method for assessing aortic stenosis severity but is limited by...